Drug Shortage Alert Statistics for June 2022
In June 2022 we have tracked shortages in 13 countries: Austria, Belgium, Denmark, Finland, France, Germany, Hungary, Ireland, Italy, Netherlands, Sweden, Spain, United Kingdom.
Countries pursue different policies in how they consider and announce shortages. Generally we track the shortages per SKU, therefore the same product but of two different pack size, or of two different strengths would be counted as two items in our database.
Total number of shortages observed were 1136.
Shortages per country:
Hospital vs. Retail product shortages
Companies announcing shortages
A total of 130 companies were categorised as announcing some shortages in our sample markets.
Company name
Teva
Viatris
Sanofi
Pfizer
Sandoz
Novartis
Krka
Accord
MSD
Aurobindo
Orifarm
Boehringer Ingelheim
GSK
Mundipharma
Bayer
Stada
Paranova
Servier
Aspen
Johnson & Johnson
B.Braun
Organon
Zentiva
Fresenius Kabi
Cheplapharm
Dermapharm
Orion
Sterop
Grünenthal
Lilly
2care4
Takeda
TOWA
GE Healthcare
UCB
Pierre Fabre
Sun
Norgine
Alliance
AstraZeneca
AbbVie
LEO
Glenmark
Baxter
Ceres Pharma
Bausch & Lomb
Karo
Schwabe
Advanz
Menarini
Zydus
Ferring
BMS
Alfasigma
Galderma
Reckitt
Medac
Evolan
Merz
Santen
Gerot Lannach
Tillomed
Eurocept
Ceva
Wagner-Pharma
Vemedia
Advicenne
Recordati
ViiV
Valeant
Theramex
Dr. Franz Köhler Chemie
Macopharma
Roche
Rowa
Campus
Qualiphar
Pharmacenter
Abacus
Curium
Elanco
Bavarian Nordic
Piramal
Novo Nordisk
Ipsen
Clinigen
Mucos Pharma
PI Pharma
P&G
Glenwood
Xiromed
Navamedic
Will-Pharma
Hennig
Gilead
Circius
Taisho
IBSA
MDS
Gedeon Richter
Celltrion
S.P.A.
THEA
PharmaCare
Farmitalia
Dr. Reddy's
Otsuka
Boiron
Heyl
Nordic Pharma
Daiichi Sankyo
FrostPharma
Milstein
Kyowa Kirin
Pharmanovia
PannonPharma
Serb
IBIGEN
Teofarma
Carelide
CDM Lavoisier
CSL Behring
Intsel Chimos
Octapharma
Salfarm
Biogen
Pharmatex
Gebro Pharma
FG Pharma
Esteve
Occurrences
109
84
69
53
52
30
30
29
27
24
23
22
21
19
19
17
17
16
15
14
14
13
13
13
11
9
9
9
8
8
8
8
7
7
6
6
6
6
6
5
5
5
5
5
4
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Notes on our data
What we consider as a Shortage Announcement?
For us it is when a government or healthcare institution announces that a product is in shortage. It may be a shortage of a particular brand of a drug, or an SKU, such as a pack size, dosage form, or strength.
Normally we list each SKU (e.g. pack size or strength) as a separate shortage.
Hospital vs. retail - generally injection products are considered as hospital use, while all others as retail use. There are some exceptions like the adrenaline autoinjectors, which are counted towards the Retail category.
Notes on company names
Novartis and Sandoz are considered as separate companies for purposes of our reporting.
Berlin Chemie is counted as Menarini.
Tillomed is stated as is, although it has a parent company Emcure but in Europe it trades exclusively as Tillomed.
Genericon is listed as Gerrot Lannach.
ViiV listed as an independent company, even though it is a joint venture of GSK, Pfizer, Shionogi.
Krka also includes TAD.
Pensa Pharma is listed as TOWA.
